Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Related documents
Education/Academic qualification
M.D., Ph.D., 東京大学大学院医学系研究科
… → Mar 2006
External positions
Professor and Chairman, School of Medicine, Teikyo University
Apr 2018 → …
Professor, School of Medicine, Teikyo University
Apr 2017 → Mar 2018
講師, Second Department of Medicine, The University of Tokyo
Jul 2012 → Mar 2017
医長, Second Department of Medicine, The University of Tokyo
Jun 2010 → Jun 2012
医員, Second Department of Medicine, The University of Tokyo
Dec 2006 → May 2010
Research Fellow, Second Department of Medicine, The University of Tokyo
Apr 2004 → Nov 2006
Keywords
- urological cancer
- robotic surgery
- urothelial cancer
- urinary bladder cancer
- upper tract urothelial cancer
- prostate cancer
- renal cell carcinoma
- testicular germ cell tumor
Research Fields
- Urology
- Tumor diagnostics and therapeutics
- Tumor biology
Fingerprint
Dive into the research topics where TOORU NAKAGAWA is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Fluoroquinolone resistance and clinical characteristics of acute bacterial prostatitis in Japan: A multicenter study by the Japanese research group for urinary tract infection
Matsumoto, M., Hamasuna, R., Wada, K., Sadahira, T., Shigemura, K., Maeda, K., Hiyama, Y., Togo, Y., Nagasawa, S., Yamanaka, K., Shigehara, K., Kobayashi, K., Tsuchiya, H., Miyazaki, J., Nakagawa, T., Ishikawa, K., Takahashi, S., Fujimoto, N. & Yamamoto, S., Jan 2025, In: Journal of Infection and Chemotherapy. 31, 1, 102497.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis
Taguchi, S., Kawai, T., Ambe, Y., Kishitani, K., Noda, M., Kaneko, T., Miyakawa, J., Nakamura, Y., Hoshina, H., Obinata, D., Yamaguchi, K., Kakutani, S., Furuya, Y., Sato, Y., Adachi, Y., Sugimoto, K., Sato, K., Tabata, M., Tanaka, T. & Nara, K. & 18 others, , Mar 2025, In: International Journal of Urology. 32, 3, p. 270-276 7 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Primary management of prostate cancer by universal health coverage effective coverage index
Asian Prostate Cancer (A-CaP) study group, Dec 2025, In: World Journal of Urology. 43, 1, 146.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study
Taguchi, S., Kawai, T., Kurokawa, Y., Saegusa, N., Yamamoto, M., Ambe, Y., Honda, K., Maki, K., Fujii, Y., Miyakawa, J., Tokura, Y., Inoue, H., Kaneko, T., Tanaka, T., Nara, K., Kamei, J., Kakutani, S., Yamada, Y., Niimi, A. & Yamada, D. & 3 others, , May 2025, In: International Journal of Clinical Oncology. 30, 5, p. 984-992 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary urothelial carcinomas
Tsumura, K., Fujimoto, M., Tian, Y., Kawahara, T., Fujimoto, H., Maeshima, A. M., Nakagawa, T., Kume, H., Yoshida, T., Kanai, Y. & Arai, E., Jun 2024, In: Experimental and Molecular Pathology. 137, 104908.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations